Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752101 · ClinicalTrials.gov registry record
Identification of a Plasma Proteomic Signature for Lung Cancer
A clinical trial, sponsored by Integrated Diagnostics.
- Completed
- Registry status
- 475
- Enrollment target
NCT01752101 is a clinical trial that has completed, run by Integrated Diagnostics. The registered enrollment target is 475 participants.
The verdict
NCT01752101 has completed, sponsored by Integrated Diagnostics.
- COMPLETED
- Registry status
- 475 participants
- Enrollment target
Study Summary
The primary objective is to identify a panel of plasma and/or serum proteins that differentiates the absence or presence of lung malignancy in samples obtained from subjects enrolled in this IRB/EC approved study with pulmonary nodules.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 475 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01752101
The ClinicalTrials.gov registry entry for NCT01752101 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 475 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integrated Diagnostics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01752101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01752101 about?
NCT01752101 is a clinical study titled "Identification of a Plasma Proteomic Signature for Lung Cancer". The primary objective is to identify a panel of plasma and/or serum proteins that differentiates the absence or presence of lung malignancy in samples obtained from subjects enrolled in this IRB/EC approved study with pulmonary nodules.
What is the current status of trial NCT01752101?
This trial is currently completed. The enrollment target is 475 participants. The study started on 2012-10. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01752101?
This trial is sponsored by Integrated Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.